POC(Point Of Care) 혈액학 진단 시장 : 기회와 전략(-2035년)

Point of care hematology diagnostics refers to blood testing performed at or near the site of patient care using compact, portable analyzers, rather than in centralized laboratories. The primary purpose of POC hematology diagnostics is to enable rapid clinical decision-making by providing immediate test results, typically within minutes. This allows healthcare providers to quickly diagnose conditions such as anemia, infections, and other blood disorders, initiate timely treatment, and monitor patient status in real time.

The point of care hematology diagnostics market consists of sales by entities (organizations, sole traders and partnerships) of point of care hematology diagnostics encompass portable analyzers, handheld devices, cartridges and reagents designed to measure key hematological indicators such as red and white blood cell counts, hemoglobin levels, hematocrit, platelet counts and coagulation parameters.

The global point of care hematology diagnostics market was valued at $1,947.5 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 8.00%.

Growing Awareness And Screening Programs For Anemia And Blood-Related Conditions

During the historic period, the point of care hematology diagnostics market was driven by the shift towards growing awareness and screening programs for anemia and blood-related conditions. Awareness and screening programs for anemia and blood-related conditions are organized public health initiatives aimed at educating people about these disorders and systematically testing individuals to detect them early for timely diagnosis and treatment. Awareness and screening programs for anemia and blood-related conditions enhance the demand for point-of-care diagnostics by enabling early detection, increasing testing frequency, and driving the need for rapid, accessible, and decentralized blood testing solutions. For instance, in August 2025, according to the Ministry of Health and Family Welfare (MoHFW), India's premier agency is Under the National Sickle Cell Anemia Elimination Mission, the Indian Council of Medical Research has validated 30 point-of-care tests and 5 non-rapid diagnostic assays for SCD screening, with over 6 crore individuals screened across 17 tribal-dominated states as of July 2025. Therefore, the point of care hematology diagnostics market was driven by the shift towards growing awareness and screening programs for anemia and blood-related conditions during the historic period.

Biotechnology, Genomics And Precision Medicine

Major companies operating in the point of care hematology diagnostics market are increasingly integrating biotechnology, genomics, and precision medicine approaches to enhance the accuracy, speed, and clinical relevance of blood testing at decentralized care settings. This trend focuses on leveraging biological insights, including genetic predispositions, molecular blood signatures, immune response patterns, and patient-specific hematological variability, to improve interpretation of complete blood count (CBC) and related parameters. By combining advanced diagnostic technologies such as microfluidics, AI-driven blood cell morphology analysis, and digital pathology with precision medicine frameworks, companies can move beyond conventional static blood counts toward more context-aware and patient-specific hematology insights. This approach enables earlier disease detection, improved monitoring of conditions such as anemia, infections, and hematologic disorders, and better treatment decision-making at the point of care.

The global point of care hematology diagnostics market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 24.27% of the total market in 2024.

Point Of Care Hematology Diagnostics Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global point of care hematology diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for point of care hematology diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The point of care hematology diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider point of care hematology diagnostics market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market
• Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Global Market Size And Growth Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by type into, by mode of prescription, by end user channel in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Recent Developments Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for point of care hematology diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type Into: Complete Blood Count; Coagulation Testing; Hemoglobin Testing; Anemia Diagnosis; Other Types
• 2) By Mode Of Prescription: Prescription-Based Product; Over-The-Counter Based Product.
• 3) By End User: Diagnostic Centers; Hospitals; Blood Banks; Transfusion Centers; Other End Users
• Companies Mentioned: Danaher Corporation (HemoCue AB); F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Siemens Healthineers; Sysmex Corporation
• Countries: China; Germany; Japan; UK; France; India; USA; Canada; South Korea; Brazil; Australia; Russia; Spain; Italy; Indonesia; Taiwan
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; point of care hematology diagnostics indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Dashboard

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Point Of Care Hematology Diagnostics Market Definition And Segmentations
• 6.4 Market Segmentation By Type (Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis And Other Types)
• 6.5 Market Segmentation By Mode Of Prescription (Prescription Based Product And Over-The-Counter Based Product)
• 6.6 Market Segmentation By End User (Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers And Other End Users)

7 Point Of Care Hematology Diagnostics Market, Overview Of Key Products/Services

• 7.1 Global Point Of Care Hematology Diagnostics Market Attractiveness Scoring And Analysis
  • 7.1.1 Overview Of Market Attractiveness Framework
  • 7.1.2 Quantitative Scoring Methodology
  • 7.1.3 Market Attractiveness Scoring And Interpretation
  • 7.1.4 Factor-Wise Evaluation
  • 7.1.5 Strategic Implications And Recommendations

8 Point Of Care Hematology Diagnostics Market, Supply Chain Analysis

• 8.1 Overview of the Supply Chain and Ecosystem
• 8.2 Resources
  • 8.2.1 List Of Key Raw Materials And Resource Providers
• 8.3 Manufacturers
  • 8.3.1 List Of Manufacturers (Suppliers)
• 8.4 Distribution
  • 8.4.1 List Of Major Distributors and Channel Partners
• 8.5 End Users
  • 8.5.1 List Of Major End Users

9 Major Market Trends

• 9.1 Key Technologies & Future Trends
  • 9.1.1 Biotechnology, Genomics And Precision Medicine
  • 9.1.2 Artificial Intelligence And Autonomous Intelligence
  • 9.1.3 Internet of Things (IoT), Smart Infrastructure And Connected Ecosystems
  • 9.1.4 Digitalization, Cloud, Big Data And Cybersecurity
  • 9.1.5 Industry 4.0 And Intelligent Manufacturing
• 9.2 Major Trends
  • 9.2.1 AI-Powered Portable Systems Revolutionize Rapid Blood Analysis For Faster Clinical Decisions
  • 9.2.2 Advancements In Compact In-Clinic Hematology Analyzers For Rapid And Decentralized Blood Testing
  • 9.2.3 Integration Of Multimodal Benchtop Analyzers Enabling Rapid Decentralized Blood Testing And Faster Clinical Decision-Making
  • 9.2.4 Advancements In AI-Enabled Cartridge-Based Blood Analysis For Rapid And Accurate On-Site Diagnostics
  • 9.2.5 Next-Generation Low-Volume Blood Testing Transforming Diagnostics

10 Point Of Care Hematology Diagnostics Growth Analysis And Strategic Analysis Framework

• 10.1 Global Point Of Care Hematology Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
  • 10.1.1 Political
  • 10.1.2 Economic
  • 10.1.3 Social
  • 10.1.4 Technological
  • 10.1.5 Environmental
  • 10.1.6 Legal
• 10.2 Analysis Of End User (B2B)
  • 10.2.1 Diagnostic Centers
  • 10.2.2 Hospitals
  • 10.2.3 Blood Banks
  • 10.2.4 Transfusion Centers
  • 10.2.5 Other End Users

11 Global Point Of Care Hematology Diagnostics Market Size And Growth Analysis

• 11.1 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 11.1.1 Market Drivers 2020 - 2025
  • 11.1.2 Market Restraints 2020 - 2025
• 11.2 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
• 11.3 Forecast Growth Contributors/Factors
  • 11.3.1 Quantitative Growth Contributors
  • 11.3.2 Drivers
  • 11.3.3 Restraints

12 Global Point Of Care Hematology Diagnostics Total Addressable Market (TAM) Analysis

• 12.1 Definition And Scope of Total Addressable Market (TAM)
• 12.2 Methodology And Assumptions
  • 12.2.1 Total Addressable Market for the Point Of Care Hematology Diagnostics Market - Business to Business (B2B)
  • 12.2.2 TAM Comparison Analysis

13 Global Point Of Care Hematology Diagnostics Market Segmentation

• 13.1 Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.2 Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.3 Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.4 Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.5 Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.6 Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.7 Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.8 Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

14 Point Of Care Hematology Diagnostics Market, Regional and Country Analysis

• 14.1 Global Point Of Care Hematology Diagnostics Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.2 Global Point Of Care Hematology Diagnostics Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 Asia-Pacific Market

• 15.1 Asia-Pacific Market Summary
• 15.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 15.3 Asia Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.4 Asia Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.5 Asia Pacific Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.6 China Market
  • 15.6.1 China Market Summary
  • 15.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 15.6.3 China Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.6.4 China Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.6.5 China Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.7 India Market
  • 15.7.1 India Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.7.2 India Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.7.3 India Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.8 Japan Market
  • 15.8.1 Japan Market Summary
  • 15.8.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 15.8.3 Japan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.8.4 Japan Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.8.5 Japan Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.9 Australia Market
  • 15.9.1 Australia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.9.2 Australia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.9.3 Australia Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.10 South Korea Market
• 15.11 South Korea Market Summary
  • 15.11.1 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 15.11.2 South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.11.3 South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.11.4 South Korea Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.12 Taiwan Market
• 15.13 Taiwan Market Summary
  • 15.13.1 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 15.13.2 Taiwan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.13.3 Taiwan Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.13.4 Taiwan Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 South East Asia Market

• 16.1 South East Asia Market Summary
• 16.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
• 16.3 South East Asia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.4 South East Asia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.5 South East Asia Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.6 Indonesia Market
  • 16.6.1 Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.6.2 Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.6.3 Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Western Europe Market

• 17.1 Western Europe Market Summary
• 17.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 17.3 Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.4 Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.5 Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.6 UK Market
  • 17.6.1 UK Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6.2 UK Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6.3 UK Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.7 Germany Market
  • 17.7.1 Germany Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7.2 Germany Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7.3 Germany Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.8 France Market
  • 17.8.1 France Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.8.2 France Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.8.3 France Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.9 Italy Market
  • 17.9.1 Italy Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.9.2 Italy Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.9.3 Italy Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.10 Spain Market
  • 17.10.1 Spain Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.10.2 Spain Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.10.3 Spain Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 Eastern Europe Market

• 18.1 Eastern Europe Market Summary
• 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
• 18.3 Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.4 Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.5 Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.6 Russia Market
  • 18.6.1 Russia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6.2 Russia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6.3 Russia Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 North America Market

• 19.1 North America Market Summary
• 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 19.3 North America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.4 North America Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.5 North America Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.6 USA Market
  • 19.6.1 USA Market Summary
  • 19.6.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 19.6.3 USA Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.6.4 USA Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.6.5 USA Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.7 Canada Market
  • 19.7.1 Canada Market Summary
  • 19.7.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 19.7.3 Canada Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.7.4 Canada Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.7.5 Canada Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 South America Market

• 20.1 South America Market Summary
• 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 20.3 South Ameria Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.4 South Ameria Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.5 South Ameria Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.6 Brazil Market
  • 20.6.1 Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.6.2 Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.6.3 Brazil Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 Middle East Market

• 21.1 Middle East Market Summary
• 21.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 21.3 Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.4 Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.5 Middle East Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

22 Africa Market

• 22.1 Africa Market Summary
• 22.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
• 22.3 Africa Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.4 Africa Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.5 Africa Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

23 Competitive Landscape And Company Profiles

• 23.1 Point Of Care Hematology Diagnostics Market Competitive Landscape And & Market Share 2024
  • 23.1.1 Top 10 Companies (Ranked by revenue/share)
• 23.2 Company Profiles
• 23.3 Danaher Corporation (HemoCue AB) (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 23.4 F. Hoffmann-La Roche Ltd. (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 23.5 Abbott Laboratories (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 23.6 Siemens Healthineers (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 23.7 Sysmex Corporation (Company Overview, Products and Services, Business Strategy, Financial Overview)

24 Other Major And Innovative Companies

• 24.1 Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (Company Overview, Products and Services)
• 24.2 Instrumentation Laboratory (Werfen) (Company Overview, Products and Services)
• 24.3 Nova Biomedical Corp. (Company Overview, Products and Services)
• 24.4 Chengdu Seamaty Technology Co. Ltd. (Company Overview, Products and Services)
• 24.5 Edan Instruments Inc. (Company Overview, Products and Services)
• 24.6 Drucker Diagnostics (Company Overview, Products and Services)
• 24.7 DIAGON Kft. (Company Overview, Products and Services)
• 24.8 Boule Diagnostics AB (Company Overview, Products and Services)
• 24.9 A Menarini Industrie Farmaceutiche Srl (Company Overview, Products and Services)
• 24.10 Transasia Bio-Medicals Ltd. (Company Overview, Products and Services)
• 24.11 Medsource Ozone Biomedicals Pvt. Ltd. (Company Overview, Products and Services)
• 24.12 EKF Diagnostics Holdings plc (Company Overview, Products and Services)
• 24.13 BioMedomics Inc. (Company Overview, Products and Services)
• 24.14 PixCell Medical Technologies Ltd. (Company Overview, Products and Services)
• 24.15 HORIBA Ltd. (Company Overview, Products and Services)

25 Competitive Benchmarking

26 Competitive Dashboard

27 Point Of Care Hematology Diagnostics Market - Company Scoring Matrix

• 27.1 Innovation & Brand Leaders
• 27.2 Brand-Driven Traditionalists
• 27.3 Niche or Regional Followers
• 27.4 Emerging Innovators

28 Upcoming Startups In the Market

29 Key Mergers And Acquisitions

• 29.1 Mars Inc Acquired Heska Corporation

30 Recent Developments

• 30.1 AI-Driven Milab BCM Enhances Point-Of-Care Hematology Diagnostics In Mexico

31 Opportunities And Strategies

• 31.1 Global Point Of Care Hematology Diagnostics Market In 2030 - Countries Offering Most New Opportunities
• 31.2 Global Point Of Care Hematology Diagnostics Market In 2030 - Segments Offering Most New Opportunities
• 31.3 Global Point Of Care Hematology Diagnostics Market In 2030 - Growth Strategies
  • 31.3.1 Market Trend Based Strategies
  • 31.3.2 Competitor Strategies

32 Point Of Care Hematology Diagnostics Market, Conclusions And Recommendations

• 32.1 Conclusions
• 32.2 Recommendations
  • 32.2.1 Product
  • 32.2.2 Place
  • 32.2.3 Price
  • 32.2.4 Promotion
  • 32.2.5 People

33 Appendix

• 33.1 Geographies Covered
• 33.2 Market Data Sources
• 33.3 Research Methodology
• 33.4 Currencies
• 33.5 The Business Research Company
• 33.6 Copyright and Disclaimer